Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy.

Saved in:
Bibliographic Details
Title: Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy.
Authors: Cheng, Heather H.1,2, Soleau, Colleen1, Yu, Evan Y.1,2,3 evanyu@uw.edu
Source: Journal of Hematology & Oncology. 2015, Vol. 8 Issue 1, p1-5. 5p.
Database: Academic Search Ultimate
Description
ISSN:17568722
DOI:10.1186/s13045-015-0149-x